Additionally, HSP90AA1 can promote autophagy through the PI3K/Akt/mTOR signaling pathway, and inhibit apoptosis through the JNK/P38 signaling pathway to improve the drug resistance of osteosarcoma cells [18]. Here, HSP90AA1 is linked to osteosarcoma.